Effects of Intracerebroventricular Administration of Neuropeptide Y on Metabolic Gene Expression and Energy Metabolism in Male Rats

Endocrinology, Aug 2016

Neuropeptide Y (NPY) is an important neurotransmitter in the control of energy metabolism. Several studies have shown that obesity is associated with increased levels of NPY in the hypothalamus. We hypothesized that the central release of NPY has coordinated and integrated effects on energy metabolism in different tissues, resulting in increased energy storage and decreased energy expenditure (EE). We first investigated the acute effects of an intracerebroventricular (ICV) infusion of NPY on gene expression in liver, brown adipose tissue, soleus muscle, and sc and epididymal white adipose tissue (WAT). We found increased expression of genes involved in gluconeogenesis and triglyceride secretion in the liver already 2-hour after the start of the NPY administration. In brown adipose tissue, the expression of thermogenic genes was decreased. In sc WAT, the expression of genes involved in lipogenesis was increased, whereas in soleus muscle, the expression of lipolytic genes was decreased after ICV NPY. These findings indicate that the ICV infusion of NPY acutely and simultaneously increases lipogenesis and decreases lipolysis in different tissues. Subsequently, we investigated the acute effects of ICV NPY on locomotor activity, respiratory exchange ratio, EE, and body temperature. The ICV infusion of NPY increased locomotor activity, body temperature, and EE as well as respiratory exchange ratio. Together, these results show that an acutely increased central availability of NPY results in a shift of metabolism towards lipid storage and an increased use of carbohydrates, while at the same time increasing activity, EE, and body temperature.

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://academic.oup.com/endo/article-pdf/157/8/3070/8994211/endo3070.pdf

Effects of Intracerebroventricular Administration of Neuropeptide Y on Metabolic Gene Expression and Energy Metabolism in Male Rats

Endocrine Society Received February Effects of Intracerebroventricular Administration of Neuropeptide Y on Metabolic Gene Expression and Energy Metabolism in Male Rats Yan Su 0 Ewout Foppen 0 Eric Fliers 0 Andries Kalsbeek 0 0 Hypothalamic Integration Mechanisms (Y.S., A.K.), Netherlands Institute for Neuroscience , 1105 BA Amsterdam , The Netherlands; and Department of Endocrinology and Metabolism (E.Fo.,E.Fl., A.K.), Academic Medical Center, University of Amsterdam , 1105 AZ Amsterdam , The Netherlands Neuropeptide Y (NPY) is an important neurotransmitter in the control of energy metabolism. Several studies have shown that obesity is associated with increased levels of NPY in the hypothalamus. We hypothesized that the central release of NPY has coordinated and integrated effects on energy metabolism in different tissues, resulting in increased energy storage and decreased energy expenditure (EE). We first investigated the acute effects of an intracerebroventricular (ICV) infusion of NPY on gene expression in liver, brown adipose tissue, soleus muscle, and sc and epididymal white adipose tissue (WAT). We found increased expression of genes involved in gluconeogenesis and triglyceride secretion in the liver already 2-hour after the start of the NPY administration. In brown adipose tissue, the expression of thermogenic genes was decreased. In sc WAT, the expression of genes involved in lipogenesis was increased, whereas in soleus muscle, the expression of lipolytic genes was decreased after ICV NPY. These findings indicate that the ICV infusion of NPY acutely and simultaneously increases lipogenesis and decreases lipolysis in different tissues. Subsequently, we investigated the acute effects of ICV NPY on locomotor activity, respiratory exchange ratio, EE, and body temperature. The ICV infusion of NPY increased locomotor activity, body temperature, and EE as well as respiratory exchange ratio. Together, these results show that an acutely increased central availability of NPY results in a shift of metabolism towards lipid storage and an increased use of carbohydrates, while at the same time increasing activity, EE, and body temperature. (Endocrinology 157: 3070 -3085, 2016) Abbreviations: AR, adrenoceptor; BAT, brown adipose tissue; BW, body weight; EE, energy expenditure; eWAT, epididymal WAT; Gapdh, glyceraldehyde 3-phosphate dehydrogenase; Hprt, hypoxanthine guanine phosphoribosyl transferase; ICV, intracerebroventricular; NPY, neuropeptide Y; RER, respiratory exchange ratio; sMuscle, soleus muscle; SNS, sympathetic nervous system; sWAT, sc WAT; Tbp, TATA box-binding protein; TG, triglyceride; 3V, third ventricle; UCP, uncoupling protein; VCO2, CO2 production; VO2, O2 consumption; WAT, white adipose tissue. - Ntide, which is widely expressed in the central ( 1 ) and europeptide Y (NPY) is a 36-amino acid neuropepperipheral nervous system ( 2 ). In the brain, NPY is found in many brain areas ( 3 ), including the hypothalamus, dentate gyrus, lateral thalamus, and striatum, with highest concentrations in the arcuate nucleus of the hypothalamus. NPY is the most potent orexigenic neuropeptide known thus far. The stimulatory effect of NPY on feeding is seen after intracerebroventricular (ICV) infusion of NPY in the lateral ( 4 ) and third ventricle (3V) ( 5 ), as well as after local infusion in specific brain areas ( 6, 7 ), including the paraventricular nucleus of the hypothalamus (8), the lateral hypothalamus ( 7 ), the nucleus accumbens ( 9 ), and the ventral tegmental area ( 9 ). Administration of NPY into the hypothalamus or ventricular system also strongly affects energy metabolism, because it increases hepatic glucose production ( 10, 11 ), triglyceride production (12), white adipose tissue (WAT) lipoprotein lipase activity ( 13 ), while decreasing hepatic insulin sensitivity ( 10, 11 ) and thermogenesis ( 13–15 ). These findings clearly show that central administration of NPY has profound metabolic effects throughout the body. Together, these data indicate that the coordinated action of NPY is to promote energy storage and decrease energy expenditure (EE). One characteristic of obesity is the excessive intake, synthesis and storage of lipids as fat. This overproduction of fat is associated with increased lipogenesis in different organs, such as liver and WAT ( 16, 17 ). Several studies found that obesity is associated with elevated levels of NPY in the hypothalamus ( 18 –22 ). Therefore, it has been speculated that a derangement of the hypothalamic NPY system may play an important role in the development of obesity. However, most of the studies investigating the effects of NPY reported on isolated observations in single organs instead of whole body effects in all major metabolic organs. Liver, WAT, brown adipose tissue (BAT), and muscle are important organs when it comes to the regulation of energy metabolism. A disturbance of metabolic processes, such as thermogenesis (...truncated)


This is a preview of a remote PDF: https://academic.oup.com/endo/article-pdf/157/8/3070/8994211/endo3070.pdf

Su, Yan, Foppen, Ewout, Fliers, Eric, Kalsbeek, Andries. Effects of Intracerebroventricular Administration of Neuropeptide Y on Metabolic Gene Expression and Energy Metabolism in Male Rats, Endocrinology, 2016, pp. 3070-3085, Volume 157, Issue 8, DOI: 10.1210/en.2016-1083